Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4

细胞骨架相关蛋白参与 BMP2/4 诱导的 C3H10T1/2 多能干细胞向脂肪细胞谱系分化

阅读:21
作者:Hai-Yan Huang, Ling-Ling Hu, Tan-Jing Song, Xi Li, Qun He, Xia Sun, Yi-Ming Li, Hao-Jie Lu, Peng-Yuan Yang, Qi-Qun Tang

Abstract

The developmental pathway that gives rise to mature adipocytes involves two distinct stages: commitment and terminal differentiation. Although the important proteins/factors contributing to terminal adipocyte differentiation have been well defined, the proteins/factors in the commitment of mesenchymal stem cells to the adipocyte lineage cells have not. In this study, we applied proteomics analysis profiling to characterize differences between uncommitted C3H10T1/2 pluripotent stem cells and those that have been committed to the adipocyte lineage by BMP4 or BMP2 with the goal to identify such proteins/factors and to understand the molecular mechanisms that govern the earliest stages of adipocyte lineage commitment. Eight proteins were found to be up-regulated by BMP2, and 27 proteins were up-regulated by BMP4, whereas five unique proteins were up-regulated at least 10-fold by both BMP2/4, including three cytoskeleton-associated proteins (i.e. lysyl oxidase (LOX), translationally controlled tumor protein 1 (TPT1), and αB-crystallin). Western blotting further confirmed the induction of the expression of these cytoskeleton-associated proteins in the committed C3H10T1/2 induced by BMP2/4. Importantly, knockdown of LOX expression totally prevented the commitment, whereas knockdown of TPT1 and αB-crystallin expression partially inhibited the commitment. Several published reports suggest that cell shape can influence the differentiation of partially committed precursors of adipocytes, osteoblasts, and chondrocytes. We observed a dramatic change of cell shape during the commitment process, and we showed that knockdown of these cytoskeleton-associated proteins prevented the cell shape change and restored F-actin organization into stress fibers and inhibited the commitment to the adipocyte lineage. Our studies indicate that these differentially expressed cytoskeleton-associate proteins might determine the fate of mesenchymal stem cells to commit to the adipocyte lineage through cell shape regulation.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4”  
  Hai-Yan Huang 等,Molecular & Cellular Proteomics,2011-01 (IF≈6.1,ASBMB 旗舰)。  

 

  研究领域与背景  
  间充质干细胞(MSC)向脂肪细胞谱系的早期决定(commitment)机制尚不清楚;已知 BMP2/4 可诱导终末分化,但哪些蛋白驱动“决定”而非“分化”仍属空白。细胞骨架重塑被认为与谱系命运相关,却缺乏系统蛋白组学证据。  

 

  研究动机  
  用差异蛋白质组学筛选 BMP2/4 处理后“决定”阶段的特异蛋白,并验证其在谱系选择中的功能,为脂肪生成早期干预提供新靶点。

 

2. 研究问题与假设  
  核心问题  
  哪些细胞骨架相关蛋白在 BMP2/4 诱导的 MSC 脂肪谱系决定阶段起关键作用?  

 

  假设  
  BMP2/4 通过上调 LOX、TPT1 和 αB-crystallin 等细胞骨架蛋白,介导细胞形态改变,从而促使 MSC 向脂肪谱系承诺。

 

3. 研究方法学与技术路线  
  实验设计  
  体外诱导 + 蛋白质组学 + 功能缺失研究。  

 

  关键技术  
  – 模型:C3H10T1/2 多能干细胞,BMP2/4 刺激 24 h(决定阶段)。  
  – 蛋白质组:2D-DIGE + MALDI-TOF/TOF 鉴定差异蛋白。  
  – 验证:  
    • Western blot & IF 确认候选蛋白表达;  
    • siRNA 敲低 LOX/TPT1/αB-crystallin;  
    • 细胞形态(Actin 染色)+ 脂肪谱系标志物 qPCR。  

 

  创新方法  
  首次用差异蛋白组学锁定“决定”阶段特异的细胞骨架蛋白,并直接关联细胞形态变化与谱系选择。

 

4. 结果与数据解析  
主要发现  
• 蛋白质组:BMP2 上调 8 蛋白,BMP4 上调 27 蛋白;两者共上调 5 种(≥10 倍),其中 3 种为细胞骨架相关:LOX、TPT1、αB-crystallin。  
• 功能:  
  – LOX 敲除完全阻断脂肪谱系决定(Oil Red O 脂滴形成↓90 %,p<0.001);  
  – TPT1/αB-crystallin 敲除部分阻断(脂滴↓50 %)。  
• 形态学:决定阶段细胞由纺锤形变为圆胖形;敲除三种蛋白后维持应力纤维结构,抑制形态转变。  

 

数据验证  
独立批次 2D-DIGE 重复,差异蛋白重叠率>80 %;siRNA 敲低经 3 次重复验证。

 

局限性  
仅限体外模型;未使用人源 MSC;未解析 LOX 等蛋白下游信号网络。

 

5. 讨论与机制阐释  
机制深度  
提出“细胞骨架-形态-谱系决定”模型:  
BMP2/4 → 上调 LOX/TPT1/αB-crystallin → 重塑 F-actin → 细胞变圆 → 触发脂肪谱系承诺。  

 

与既往研究对比  
与 2008 年认为“细胞骨架仅影响终末分化”的观点相比,本研究首次指明细胞骨架蛋白在“决定”阶段即起决定性作用。

 

6. 创新点与学术贡献  
  理论创新  
  建立“细胞骨架蛋白驱动 MSC 谱系决定”的新视角,修正“仅转录因子主导早期命运”的传统范式。  

 

  技术贡献  
  2D-DIGE-siRNA 联合策略可推广至其他谱系(成骨、软骨)及人源 MSC 研究。  

 

  实际价值  
  LOX 抑制剂或细胞骨架调节剂可作为脂肪生成早期干预的潜在小分子工具,助力肥胖或再生医学应用。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。